S&P 500 Surges 1.1% as Moderna Stock Pops on Cancer Vaccine Optimism and Trumps Tariff Reprieve
B
2 minutes read
The S&P 500 advanced 1.1% on Wednesday, driven by a delay in tariffs affecting U.S. automakers and optimism over Moderna's cancer vaccine, with shares surging 15.9% after a top executive announced a 2027 release.
Related Tags
Related Articles
Trumps Tariff Twist: How a One-Month Exemption Sent Stocks Soaring, Including the Nasdaq Composite
2 months ago
The American Exceptionalism Trade: How Donald Trumps Policies Are Impacting the US Economy and Stock Market
2 months ago
Flu Season Trends and Vaccination Importance
3 months ago
Trump Grants One-Month Reprieve on Tariffs for US Automakers: A Temporary Solution to a Looming Trade War
2 months ago
Trump Grants 1-Month Tariff Exemption to Ford, GM, and Stellantis After Call with Automakers
2 months ago